Angina Pectoris Following Latanoprostene Bunod 0.024% Administration: A Case Report. [PDF]
Edakkavil Z +4 more
europepmc +1 more source
Unexpected coronary vasospasm: a case of systemic minoxidil-induced angina pectoris. [PDF]
Pavrey R, Chauhan V.
europepmc +1 more source
Efficacy, safety, and costs of nine Chinese patent medicines for the treatment of angina pectoris in CHD. [PDF]
Sun J +6 more
europepmc +1 more source
Logistic regression analysis of factors influencing NT-proBNP expression levels in patients with unstable angina pectoris and intervention strategies. [PDF]
Sun Z.
europepmc +1 more source
Feature Selection and Model Optimization for Survival Prediction in Patients with Angina Pectoris. [PDF]
Bata R, Ghanem AS, Nagy AC.
europepmc +1 more source
Geographical distribution of ALDH2 rs671 polymorphism in Chinese angina pectoris patients. [PDF]
Dong W, Yu J, Xu S, Li H.
europepmc +1 more source
Unraveling the causal link between lipidomes and unstable angina pectoris: A Mendelian randomization analysis. [PDF]
Pan W, Yu M, Chen Z.
europepmc +1 more source
Clonal haematopoiesis is associated with protection against angina pectoris in the UK population. [PDF]
Zheng Y +13 more
europepmc +1 more source
Systemic inflammatory response index in the differentiation of unstable angina pectoris and non-ST elevation myocardial infarction. [PDF]
Akyel S, Yildiz A.
europepmc +1 more source
The Effectiveness and Safety of Cardiac Shock Wave Therapy in the Treatment of Ischemic Heart Disease with Refractory Angina Pectoris. [PDF]
Thanh LD +6 more
europepmc +1 more source

